Jeffrey Gene Lee is of BlackRock Health Sciences Trust. Currently has a direct ownership of 0 shares of BME, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 204 shares (Common Stock) at a price of $43.56 per share, resulting in proceeds of $8,886. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jeffrey Gene Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
SELL
Sale (or disposition) back to the issuer
$8,886 $43.56 p/Share
204 Reduced 100.0%
0 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
-
204 Added 50.0%
204 Common Stock
Jan 31 2022
SELL
Sale (or disposition) back to the issuer
$3,202 $45.1 p/Share
71 Reduced 100.0%
0 Common Stock
Jan 31 2022
BUY
Exercise of conversion of derivative security
-
71 Added 50.0%
71 Common Stock

Also insider at

BMEZ
BlackRock Health Sciences Trust II ETFs
JGL

Jeffrey Gene Lee

New York, NY

Track Institutional and Insider Activities on BME

Follow BlackRock Health Sciences Trust and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BME shares.

Notify only if

Insider Trading

Get notified when an Black Rock Health Sciences Trust insider buys or sells BME shares.

Notify only if

News

Receive news related to BlackRock Health Sciences Trust

Track Activities on BME